NE HEALTH/BUSINESS BUREAU
CHENNAI, JULY 7
In a significant stride towards the future of maternal healthcare, Aarthi Scans & Labs has strengthened its long-standing collaboration with US-based Origin Medical Research Lab India Pvt. Ltd., the research and development arm of Origin Medical, to accelerate the adoption of artificial intelligence-powered prenatal ultrasound, a breakthrough expected to make fetal diagnostics more accurate, efficient and accessible.
The five-year India-US collaboration has focused on developing and clinically validating advanced AI technologies capable of supporting radiologists and fetal medicine specialists in delivering consistent, standardised prenatal assessments across high-volume healthcare environments.
- India-US collaboration leverages artificial intelligence to deliver faster, smarter and more consistent fetal diagnostics
- Five-year research partnership develops clinically validated AI tools for image capture, fetal biometry and real-time quality assessment
- Innovation aims to improve maternal healthcare access, reduce diagnostic variability and support clinicians in high-volume settings
- Global validation at premier fetal medicine forums positions India at the forefront of AI-driven prenatal imaging
The jointly developed AI platform enhances multiple stages of the prenatal ultrasound workflow, including automated image acquisition, anatomical landmark detection, real-time image quality evaluation and fetal biometry, enabling clinicians to improve diagnostic precision while reducing workflow variability and examination time.
Speaking about the collaboration, Dr. Arunkumar Govindarajan, Radiologist and Executive Director, Aarthi Scans & Labs, highlighted the transformative role of AI in strengthening maternal healthcare delivery.
“Prenatal ultrasound plays a critical role in monitoring fetal development and enabling timely clinical decisions during pregnancy. However, ensuring consistency and quality in fetal imaging across high-volume and diverse healthcare settings continues to be a challenge. Our collaboration with Origin Medical Research Lab is focused on addressing this gap through clinically validated AI solutions that can support radiologists and fetal medicine specialists in delivering more standardised and accurate prenatal assessments.”
Emphasising the broader healthcare impact, he added:
“We believe that responsible integration of AI into prenatal imaging has the potential to significantly improve access to high-quality maternal healthcare, particularly in a country like India where the demand for prenatal diagnostics continues to grow rapidly.”
The outcomes of the collaborative research, undertaken with multiple clinical and research partners, have been presented at prestigious international scientific platforms, including the ISUOG World Congress and the Fetal Medicine Foundation World Congress, where the AI systems demonstrated robust performance in identifying complete fetal anatomy, including the highly sensitive central nervous system.
The AI-enabled platform incorporates automated image capture and intelligent feedback mechanisms that help sonographers acquire comprehensive anatomical surveys with greater efficiency, reducing scan duration while enhancing patient comfort.
It also features real-time image-quality assessment and view-completeness verification, ensuring that all essential fetal anatomical views are captured in accordance with internationally accepted clinical guidelines.
Automated fetal measurement capabilities further improve the consistency of fetal biometry, minimising inter-operator variability and supporting uniform prenatal assessments across multiple healthcare centres.
Highlighting the strategic significance of the partnership, Sripad Krishna Devalla, Co-founder and CEO of Origin Medical, said Aarthi Scans & Labs has played a pivotal role in advancing the company’s AI research journey.
“Aarthi Scans & Labs has been one of our first and foundational partners from day one, and their clinical rigour, scale and commitment to innovation have been central to the progress we have made in AI-driven prenatal imaging.”
He added:
“Origin Medical Research Lab is the dedicated research and development arm of Origin Medical, and partnerships like this sit at the heart of our work—translating real-world clinical data and insights into AI solutions that are validated, scalable and meaningful. The science developed through this collaboration continues to directly shape the technologies that Origin Medical is bringing to prenatal care settings around the world.”
As one of India’s early adopters of artificial intelligence in diagnostic imaging, Aarthi Scans & Labs continues to leverage advanced technologies to improve patient outcomes, optimise radiology workflows and strengthen the detection of fetal abnormalities during routine prenatal examinations.
The collaboration forms part of a broader vision to make high-quality, affordable and standardised prenatal care more widely available across India, particularly as demand for advanced maternal-fetal diagnostics continues to rise.
The organisations emphasised that all research activities have been conducted in strict compliance with the Pre-Conception and Pre-Natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994, and other applicable regulatory requirements. The AI algorithms developed under the initiative have also undergone validation at several reputed healthcare institutions, reinforcing their clinical reliability and scalability for wider adoption.
With artificial intelligence steadily reshaping medical diagnostics worldwide, the partnership reflects India’s growing role in developing globally relevant healthcare innovations that combine cutting-edge technology with improved patient care.
